bezafibrate and its Impurities
Bezafibrate improves markers of combined hyperlipidemia, effectively reducing LDL and triglycerides and improving HDL levels. Reference standards of Bezafibrate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
(2S,3S,4S,5R,6S)-6-((2-(4-(2-(4-Chlorobenzamido)Ethyl)Phenoxy)-2-Methylpropanoyl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic Acid
(2S,3S,4S,5R,6S)-6-((2-(4-(2-(4-Chlorobenzamido)Ethyl)Phenoxy)-2-Methylpropanoyl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic Acid
Catalogue No.:PA 02 0661000
CAS :
72156-77-5
Molecular Formula : C25H28ClNO10
Molecular Weight : 537.95